CT Chest Surveillance for High-Risk Smokers

Lung Cancer Screening Benefits

The American College of Radiology recommends annual lung cancer screening with low-dose CT in high-risk smokers, which reduces lung cancer mortality by 20% and all-cause mortality by 6.7% 1

Interstitial lung abnormalities are found in approximately 8% of smokers undergoing CT screening and are associated with increased respiratory symptoms, diminished lung function, and higher mortality 2

The American Journal of Respiratory and Critical Care Medicine suggests that screening should be conducted in comprehensive programs that include structured nodule management protocols with multi-disciplinary expertise and integrated smoking cessation interventions 3, 4, 5
The American College of Chest Physicians recommends integrated smoking cessation interventions as part of screening programs, as smoking cessation remains the most effective strategy to reduce lung cancer risk and mortality 3, 4
The National Comprehensive Cancer Network recommends shared decision-making discussions that include potential benefits, limitations, and harms of screening, although this specific fact is not directly cited, a similar concept is mentioned in 6

Overdiagnosis of indolent cancers that may not have caused symptoms in a person's lifetime is possible, with an estimated rate of overdiagnosis, although the exact rate is not specified in the provided text 7

The U.S. Preventive Services Task Force guidelines recommend annual lung cancer screening with low-dose CT in well-defined groups of high-risk smokers, with a strong recommendation based on moderate-quality evidence 8

Systematic assessment and documentation of findings beyond lung nodules should be performed, including interstitial lung abnormalities, coronary calcifications, and bone density, with a focus on quality assurance measures to maximize benefits and minimize harms 2, 6

The American College of Chest Physicians recommends low-dose CT screening for high-risk individuals aged 50-80 years with at least a 20 pack-year smoking history who currently smoke or have quit within the past 15 years 9, 10
Eligibility for screening includes individuals in relatively good health who can tolerate treatment if cancer is detected, as recommended by the American Cancer Society 11

Pre-screening assessment should determine eligibility based on age, smoking history, and absence of symptoms, as recommended by the American College of Chest Physicians 12, 13
Shared decision-making should include counseling about benefits, limitations, and potential harms of screening, as recommended by the American Cancer Society 11, 14
Screening protocol should use low-dose CT technique and define positive test threshold based on nodule size, as recommended by the National Comprehensive Cancer Network 15, 16

Unnecessary diagnostic procedures for benign nodules are a potential harm of screening, as noted by the American Cancer Society 11
Radiation exposure from repeated scans is a potential harm of screening, as noted by the Journal of Thoracic Oncology 17

Screening should be performed in organized programs with quality assurance measures, as recommended by the Journal of Thoracic Oncology 17
Smoking cessation counseling should be integrated into screening programs, as recommended by the American Cancer Society and the American College of Chest Physicians 11, 14